We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid, Paper-Based Test Detects Coronavirus in Sewage and Wastewater

By LabMedica International staff writers
Posted on 06 Apr 2020
Print article
Image: The paper device for COVID-19 detection presents results that are visible to the naked eye: a green circle indicating positive and a blue circle negative (Photo courtesy of Cranfield University)
Image: The paper device for COVID-19 detection presents results that are visible to the naked eye: a green circle indicating positive and a blue circle negative (Photo courtesy of Cranfield University)
A team of British researchers has developed a rapid test to detect the COVID-19 virus, SARS-CoV-2, in sewage and wastewater as a means for gauging the level of infection within the community.

One of the characteristics of COVID-19 is that the virus can be spread by individuals who are not symptomatic, having neither fever nor signs of infection. Lacking the ability to screen these asymptomatic patients quickly and effectively, health authorities have no way of predicting the optimum time to reduce the risk of disease transmission by implementing effective quarantine measures. Thus, tracing unknown COVID-19 sources, fast and accurate screening of potential virus carriers, and diagnosis of asymptomatic patients are crucial steps for intervention and prevention at an early stage.

In this regard, investigators at Cranfield University (United Kingdom) developed a wastewater-based epidemiology (WBE) approach to provide a rapid way to predict the potential spread of COVID-19 by screening for viral biomarkers in feces and urine that enter the sewer system from disease carriers.

This concept – a paper-based rapid diagnostic device for detection of coronavirus – is an adaption of technology that had been successfully used for rapid veterinary diagnosis in India and for detection of malaria parasites in blood among rural populations in Uganda.

In practice, the paper device is folded and unfolded in steps to filter the nucleic acids of the virus from wastewater samples. Preloaded reagents in the device detect whether the nucleic acid from SARS-CoV-2 is present. Results are visible to the naked eye: a green circle indicating positive and a blue circle negative. The paper analytical devices are easy to stack, store, and transport because they are thin and lightweight, and can also be incinerated after use, reducing the risk of further contamination.

Senior author Dr. Zhugen Yang, lecturer in sensor technology at Cranfield University, said, "In the case of asymptomatic infections in the community or when people are not sure whether they are infected or not, real-time community sewage detection through paper analytical devices could determine whether there are COVID-19 carriers in an area to enable rapid screening, quarantine, and prevention. If COVID-19 can be monitored in a community at an early stage through WBE, effective intervention can be taken as early as possible to restrict the movements of that local population, working to minimize the pathogen spread and threat to public health."

The paper-based COVID-19 detection device was described in the March 23, 2020, online edition of the journal Environmental Science & Technology.

Related Links:
Cranfield University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more